Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

LifeMD Q4 2023 Adj EPS $0.15 Beats $(0.14) Estimate, Sales $44.860M Beat $40.494M Estimate

Author: Benzinga Newsdesk | March 11, 2024 04:14pm
LifeMD (NASDAQ:LFMD) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $(0.14) by 207.14 percent. The company reported quarterly sales of $44.860 million which beat the analyst consensus estimate of $40.494 million by 10.78 percent. This is a 59.53 percent increase over sales of $28.120 million the same period last year.

Posted In: LFMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist